Last10K.com

Aeon Global Health Corp. (AGHC) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Aeon Global Health Corp.

CIK: 1024657 Ticker: AGHC
Document And Entity Information - shares
3 Months Ended
Sep. 30, 2018
Oct. 25, 2018
Document Information [Line Items]  
Entity Registrant NameAeon Global Health Corp. 
Entity Central Index Key0000885074 
Trading Symbolaghc 
Current Fiscal Year End Date--06-30 
Entity Filer CategoryNon-accelerated Filer 
Entity Current Reporting StatusYes 
Entity Emerging Growth Companyfalse 
Entity Small Businesstrue 
Entity Common Stock, Shares Outstanding (in shares) 7,383,706
Document Type10-Q 
Document Period End DateSep. 30, 2018 
Document Fiscal Year Focus2019 
Document Fiscal Period FocusQ1 
Amendment Flagfalse 

View differences made from one quarter to another to evaluate Aeon Global Health Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeon Global Health Corp..

Continue

Assess how Aeon Global Health Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeon Global Health Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets (Current Period Unaudited)
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Operations
Consolidated Statements Of Shareholders' Equity
Note 1 - Description Of Business, Reverse Merger And Liquidity
Note 1 - Description Of Business, Reverse Merger And Liquidity (Details Textual)
Note 10 - Fair Value Measurements And Other Financial Instruments
Note 10 - Fair Value Measurements And Other Financial Instruments (Details Textual)
Note 10 - Fair Value Measurements And Other Financial Instruments (Tables)
Note 10 - Fair Value Measurements And Other Financial Instruments - Derivative Liabilities (Details)
Note 10 - Fair Value Measurements And Other Financial Instruments - Summary In Changes In Fair Value (Details)
Note 10 - Fair Value Measurements And Other Financial Instruments - Valuation Techniques (Details)
Note 11 - Commitments And Contingencies
Note 11 - Commitments And Contingencies (Details Textual)
Note 12 - Related Party Transactions
Note 12 - Related Party Transactions (Details Textual)
Note 13 - Segment Information
Note 13 - Segment Information (Details Textual)
Note 13 - Segment Information (Tables)
Note 13 - Segment Information - Selected Financial Information (Details)
Note 14 - Subsequent Events
Note 14 - Subsequent Events (Details Textual)
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies (Details Textual)
Note 3 - Revenue Recognition
Note 3 - Revenue Recognition (Details Textual)
Note 3 - Revenue Recognition (Tables)
Note 3 - Revenue Recognition - Revenues By Type Of Customers (Details)
Note 4 - Inventory
Note 4 - Inventory (Tables)
Note 4 - Inventory - Inventory (Details)
Note 5 - Income Taxes
Note 5 - Income Taxes (Details Textual)
Note 6 - Related Party Notes Payable
Note 6 - Related Party Notes Payable (Details Textual)
Note 6 - Related Party Notes Payable (Tables)
Note 6 - Related Party Notes Payable - Related Party Notes Payable (Details)
Note 7 - Equity
Note 7 - Equity (Details Textual)
Note 7 - Equity (Tables)
Note 7 - Equity - Earnings Per Share (Details)
Note 7 - Equity - Warrant Activity (Details)
Note 8 - Share-Based Compensation
Note 8 - Share-Based Compensation (Details Textual)
Note 8 - Share-Based Compensation (Tables)
Note 8 - Share-Based Compensation - Restricted Stock Unit Activity (Details)
Note 8 - Share-Based Compensation - Stock Option Activity (Details)
Note 9 - Earn-Out Merger Consideration
Note 9 - Earn-Out Merger Consideration (Details Textual)
Significant Accounting Policies (Policies)

Material Contracts, Statements, Certifications & more

Aeon Global Health Corp. provided additional information to their SEC Filing as exhibits

Ticker: AGHC
CIK: 885074
Form Type: 10-Q Quarterly Report
Accession Number: 0001437749-18-020324
Submitted to the SEC: Fri Nov 09 2018 5:12:50 PM EST
Accepted by the SEC: Fri Nov 09 2018
Period: Sunday, September 30, 2018
Industry: Medical Laboratories

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aghc/0001437749-18-020324.htm